Tech selloffs are rarely comfortable, but they often create unique opportunities for discerning investors. In 2026, several high-quality Australian Securities Exchange (ASX) growth stocks have been dragged lower amid broader weakness in technology shares. As sentiment turns against the sector, share prices can fall faster than fundamentals change. For investors willing to look past short-term volatility, three Australian stocks stand out as potential buys.
All three have experienced significant declines this year; however, their long-term growth stories remain compelling. Let’s delve deeper into these stocks: Life360 Inc., Pro Medicus Ltd, and Temple & Webster Group Ltd.
Life360 Inc. (ASX: 360)
Life360 operates a global family safety platform built around subscription revenue. Its core app allows families to share location data and access safety features, with revenue increasingly driven by paid plans rather than advertising. This recurring revenue model is crucial as it provides visibility and scalability.
Growth stocks like Life360 often experience outsized share price swings when markets become risk-averse. However, if subscriber growth, engagement, and monetization continue to improve, the long-term value of the platform could be significantly higher than today’s share price suggests. A shift in sentiment back toward growth names could see Life360 shares rebound quickly.
Pro Medicus Ltd (ASX: PME)
Pro Medicus has long been celebrated as one of the ASX’s standout software success stories. The company provides advanced medical imaging software to hospitals and healthcare providers globally. Its Visage platform is renowned for speed and performance, particularly in handling large imaging files.
The business model is capital-light, highly profitable, and supported by long-term contracts. Despite this, its share price has been caught up in the broader tech selloff triggered by AI disruption concerns. However, Pro Medicus has spent years developing its world-class software, backed by patents and industry trust, making it resilient against potential AI disruptions.
“If its earnings growth continues, this current share price weakness could prove temporary,” said an industry analyst.
Temple & Webster Group Ltd (ASX: TPW)
Often viewed as a discretionary retail stock, Temple & Webster’s online-only model gives it structural advantages. The company operates without the burden of a large physical store network, allowing it to scale efficiently. Over time, it has invested in brand, logistics, and customer experience to strengthen its competitive position.
Retail and technology selloffs can overlap, and Temple & Webster has felt that pressure. However, if consumer conditions stabilize and online penetration continues to grow, its earnings could recover faster than many expect.
“For patient investors, this could be a chance to buy into Australia’s leading online furniture retailer at a more reasonable price,” noted a market strategist.
Market Dynamics and Future Outlook
While a sudden spike is not anticipated next week, markets tend to overshoot in both directions. When high-growth stocks are sold indiscriminately, it creates a gap between share price and long-term potential. If broader tech sentiment improves or if these companies continue delivering strong operational results, investor confidence could return swiftly.
Life360, Pro Medicus, and Temple & Webster have all fallen heavily in 2026 amid a tech selloff. This does not automatically make them bargains, but if their long-term growth stories remain intact, the recent weakness could present a compelling opportunity.
As the tech landscape evolves, these companies’ ability to adapt and innovate will be crucial. Investors should keep a close watch on their performance metrics and market conditions to make informed decisions.
The current market environment underscores the importance of looking beyond immediate market fluctuations and focusing on the fundamental strengths of businesses poised for long-term success.
